Evotec SE (OTCMKTS:EVTCY – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.95 and traded as low as $1.9501. Evotec shares last traded at $1.96, with a volume of 50,289 shares traded.
Evotec Stock Performance
The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The stock has a 50 day simple moving average of $2.61 and a 200 day simple moving average of $2.94. The company has a market capitalization of $637.33 million, a price-to-earnings ratio of 4.71 and a beta of 0.98.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Further Reading
- Five stocks we like better than Evotec
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
